{"effective_time":"20181218","id":"383a124f-26a8-4d98-9c1a-af959b1275e2","openfda":{},"package_label_principal_display_panel":["Principal Display Panel - Mylan Yupelri 175 mcg 7 ct Singles Trade Shelf Carton NDC 49502-806-77 Rx only YUPELRI (revefenacin) inihalation solution 175 mcg/3 mL For Oral Inhalation Only PHARMACIST: Dispense the enclosed Medication Guide to each patient. 7 sterile unit-dose vials Theravance Biopharma Mylan 7 ct singles carton","Principal Display Panel - Mylan Yupelri 175 mcg 30 ct Singles Trade Shelf Carton NDC 49502-806-93 Rx only YUPELRI (revefenacin) inihalation solution 175 mcg/3 mL For Oral Inhalation Only PHARMACIST: Dispense the enclosed Medication Guide to each patient. 30 sterile unit-dose vials Theravance Biopharma Mylan 30 ct singles carton"],"set_id":"7d523201-52b2-3d74-e053-2991aa0a5f0e","spl_product_data_elements":["Yupelri Revefenacin REVEFENACIN REVEFENACIN"],"spl_unclassified_section":["Contents: Each vial contains 175 mcg of revefenacin in an isotonic, sterile aqueous solution containing sodium chloride, citric acid and sodium citrate. Storage: Store YUPELRI (revefenacin) inhalation solution in the protective foil pouch. Store at room temperature from 68°F to 77°F (20°C to 25°C); excursions permitted from 59°F to 86°F (15°C to 30°C) [See USP Controlled Room Temperature].Protect from direct sunlight and excessive heat. The YUPELRI unit-dose vial should only be removed from the foil pouch and opened IMMEDIATELY BEFORE USE. The vial and any residual content should be discarded after use. Discard any solution that is not clear and colorless. Use only as directed by your healthcare provider. Keep out of reach of children. Not a child-resistant package. Manufactured for: Mylan Specialty L.P. Morgantown, WV 26505 USA Made in USA Licensed from: Theravance Biopharma Ireland Limited Copyright © 2018 Mylan Specialty L.P. All rights reserved. YUPELRI is a registered trademark of Mylan Specialty L.P., Morgantown, WV 26505 USA Patented. See YUPELRI.com/patents"],"version":"5"}